ARQT stock

Arcutis Biotherapeutics Inc (ARQT) net margin is -61.0%

Arcutis Biotherapeutics Inc (ARQT) net margin is -61.0% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.

Read the full ARQT research page for quote, filings, and the rest of the model. This satellite exists so “Arcutis Biotherapeutics Inc net margin” can rank with the actual number, then send you to /stock/arqt.

Full ARQT analysis